References
Key articles
Centers for Disease Control and Prevention. Interim guidance on testing and specimen collection for patients with suspected infection with novel influenza A viruses with the potential to cause severe disease in humans. Mar 2022 [internet publication].Full text
Centers for Disease Control and Prevention. Interim guidance on follow-up of close contacts of persons infected with novel influenza A viruses and use of antiviral medications for chemoprophylaxis. Mar 2022 [internet publication].Full text
World Health Organization. Guidelines for the clinical management of severe illness from influenza virus infections. 2022 [internet publication].Full text
Centers for Disease Control and Prevention. Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. Mar 2022 [internet publication].Full text
Reference articles
1. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, et al; Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2008 Jan 17;358(3):261-73.Full text Abstract
2. World Health Organization. Human infection with avian influenza A(H7N9) virus - China. Feb 2017 [internet publication].Full text
3. Yang JR, Liu MT. Human infection caused by an avian influenza A (H7N9) virus with a polybasic cleavage site in Taiwan, 2017. J Formos Med Assoc. 2017 Mar;116(3):210-2.Full text Abstract
4. Yu H, Cowling BJ, Feng L, et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet. 2013 Jul 13;382(9887):138-45.Full text Abstract
5. Chen Y, Liang W, Yang S, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013 Jun 1;381(9881):1916-25. Abstract
6. Yu X, Jin T, Cui Y, et al. Influenza H7N9 and H9N2 viruses: coexistence in poultry linked to human H7N9 infection and genome characteristics. J Virol. 2014 Mar;88(6):3423-31.Full text Abstract
7. Li Q, Zhou L, Zhou M, et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med. 2014 Feb 6;370(6):520-32.Full text Abstract
8. Qi X, Qian YH, Bao CJ, et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ. 2013 Aug 6;347:f4752.Full text Abstract
9. Xiang N, Iuliano AD, Zhang Y, et al. Comparison of the first three waves of avian influenza A(H7N9) virus circulation in the mainland of the People's Republic of China. BMC Infect Dis. 2016 Dec 5;16(1):734.Full text Abstract
10. Wang X, Wu P, Pei Y, et al. Assessment of human-to-human transmissibility of avian influenza A(H7N9) virus across 5 waves by analyzing clusters of case patients in mainland China, 2013-2017. Clin Infect Dis. 2019 Feb 1;68(4):623-31.Full text Abstract
11. Zhou L, Chen E, Bao C, et al. Clusters of human infection and human-to-human transmission of avian influenza A(H7N9) virus, 2013-2017. Emerg Infect Dis. 2018 Feb 17;24(2):397-400.Full text Abstract
12. Skowronski DM, Tweed SA, Petric M, et al. Human illness and isolation of low-pathogenicity avian influenza virus of the H7N3 subtype in British Columbia, Canada. J Infect Dis. 2006 Mar 15;193(6):899-900.Full text Abstract
13. Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet. 1999 Sep 11;354(9182):916-7. Abstract
14. Uyeki TM, Chong YH, Katz JM, et al. Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999. Emerg Infect Dis. 2002 Feb;8(2):154-9.Full text Abstract
15. Avian influenza A/(H7N2) outbreak in the United Kingdom. Euro Surveill. 2007 May 31;12(5):E070531.2. Abstract
16. Kurtz J, Manvell RJ, Banks J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet. 1996 Sep 28;348(9031):901-2. Abstract
17. Tong XC, Weng SS, Xue F, et al. First human infection by a novel avian influenza A(H7N4) virus. J Infect. 2018 Jun 10;77(3):249-57. Abstract
18. Tweed SA, Skowronski DM, David ST, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis. 2004 Dec;10(12):2196-9.Full text Abstract
19. Nguyen-Van-Tam JS, Nair P, Acheson P, et al. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill. 2006 May 4;11(5):E060504.2. Abstract
20. International Society for Infectious Diseases. ProMED-mail. Avian influenza (59): China (SC) LPAI H5N6, human, first case, poultry. May 2014 [internet publication].Full text
21. Zhou L, Tan Y, Kang M, et al. Preliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017. Emerg Infect Dis. 2017 Aug;23(8):1355-9.Full text Abstract
22. Liu D, Shi W, Shi Y, et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet. 2013 Jun 1;381(9881):1926-32. Abstract
23. Lam TT, Wang J, Shen Y, et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature. 2013 Oct 10;502(7470):241-4.Full text Abstract
24. Lu J, Wu J, Zeng X, et al. Continuing reassortment leads to the genetic diversity of influenza virus H7N9 in Guangdong, China. J Virol. 2014 Aug;88(15):8297-306.Full text Abstract
25. Pantin-Jackwood MJ, Miller PJ, Spackman E, et al. Role of poultry in the spread of novel H7N9 influenza virus in China. J Virol. 2014 May;88(10):5381-90.Full text Abstract
26. Iuliano AD, Jang Y, Jones J, et al. Increase in human infections with avian influenza A(H7N9) virus during the fifth epidemic - China, October 2016-February 2017. MMWR Morb Mortal Wkly Rep. 2017 Mar 10;66(9):254-5.Full text Abstract
27. Ocaña-Macchi M, Bel M, Guzylack-Piriou L, et al. Hemagglutinin-dependent tropism of H5N1 avian influenza virus for human endothelial cells. J Virol. 2009 Dec;83(24):12947-55.Full text Abstract
28. Baigent SJ, McCauley JW. Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission. Bioessays. 2003 Jul;25(7):657-71. Abstract
29. Richard M, Herfst S, van den Brand JM, et al. Low virulence and lack of airborne transmission of the Dutch highly pathogenic avian influenza virus H5N8 in ferrets. PLoS One. 2015 Jun 19;10(6):e0129827.Full text Abstract
30. Richard M, Schrauwen EJ, de Graaf M, et al. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature. 2013 Sep 26;501(7468):560-3.Full text Abstract
31. Zhou J, Wang D, Gao R, et al. Biological features of novel avian influenza A (H7N9) virus. Nature. 2013 Jul 25;499(7459):500-3. Abstract
32. Hay AJ, Hayden FG. Oseltamivir resistance during treatment of H7N9 infection. Lancet. 2013 Jun 29;381(9885):2230-2. Abstract
33. Hu Y, Lu S, Song Z, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet. 2013 Jun 29;381(9885):2273-9. Abstract
34. Liu X, Li T, Zheng Y, et al. Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection. Emerg Microbes Infect. 2013 May;2(5):e27.Full text Abstract
35. Marjuki H, Mishin VP, Chesnokov AP, et al. Neuraminidase mutations conferring resistance to oseltamivir in influenza A(H7N9) viruses. J Virol. 2015 May;89(10):5419-26.Full text Abstract
36. Marjuki H, Mishin VP, Chesnokov AP, et al. Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. J Infect Dis. 2015 Jan 15;211(2):249-57.Full text Abstract
37. Gao HN, Yao HP, Liang WF, et al. Viral genome and antiviral drug sensitivity analysis of two patients from a family cluster caused by the influenza A(H7N9) virus in Zhejiang, China, 2013. Int J Infect Dis. 2014 Dec;29:254-8.Full text Abstract
38. European Centre for Disease Prevention and Control. Influenza A(H7N9) virus in China: implications for public health. Seventh update. Jul 2017 [internet publication].Full text
39. Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013 May 16;368(20):1888-97.Full text Abstract
40. Tang J, Zhang J, Zhou J, et al. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts. Virol J. 2019 Jul 2;16(1):87.Full text Abstract
41. Olson SH, Gilbert M, Cheng MC, et al. Historical prevalence and distribution of avian influenza virus A(H7N9) among wild birds. Emerg Infect Dis. 2013 Dec;19(12):2031-3.Full text Abstract
42. Ip DK, Liao Q, Wu P, et al. Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series. BMJ. 2013 Jun 24;346:f3693.Full text Abstract
43. World Health Organization. Surveillance - avian influenza. 2022 [internet publication].Full text
44. Uyeki TM, Katz JM, Jernigan DB. Novel influenza A viruses and pandemic threats. Lancet. 2017 Jun 3;389(10085):2172-4. Abstract
45. Wang X, Jiang H, Wu P, et al. Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series. Lancet Infect Dis. 2017 Aug;17(8):822-32. Abstract
46. Kile JC, Ren R, Liu L, et al. Update: increase in human infections with novel Asian lineage avian influenza A(H7N9) viruses during the fifth epidemic - China, October 1, 2016-August 7, 2017. MMWR Morb Mortal Wkly Rep. 2017 Sep 8;66(35):928-32.Full text Abstract
47. Yuan J, Lau EH, Li K, et al. Effect of live poultry market closure on avian influenza A(H7N9) virus activity in Guangzhou, China, 2014. Emerg Infect Dis. 2015 Oct;21(10):1784-93.Full text Abstract
48. Yu H, Wu JT, Cowling BJ, et al. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet. 2014 Feb 8;383(9916):541-8.Full text Abstract
49. Li Y, Wang Y, Shen C, et al. Closure of live bird markets leads to the spread of H7N9 influenza in China. PLoS One. 2018 Dec 12;13(12):e0208884.Full text Abstract
50. Wu J, Ke C, Lau EH, et al. Influenza H5/H7 virus vaccination in poultry and reduction of zoonotic infections, Guangdong Province, China, 2017-18. Emerg Infect Dis. 2019 Jan 17;25(1):116-8.Full text Abstract
51. Cheng W, Chong KC, Lau SY, et al. Comparison of avian influenza virus contamination in the environment before and after massive poultry H5/H7 vaccination in Zhejiang Province, China. Open Forum Infect Dis. 2019 Apr 24;6(6):ofz197.Full text Abstract
52. Chang SY, Lin PH, Tsai JC, et al. The first case of H7N9 influenza in Taiwan. Lancet. 2013 May 11;381(9878):1621. Abstract
53. Ho PL, Sin WC, Chan JF, et al. Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir. Eur Respir J. 2014 Aug;44(2):535-7.Full text Abstract
54. William T, Thevarajah B, Lee SF, et al. Avian influenza (H7N9) virus infection in Chinese tourist in Malaysia, 2014. Emerg Infect Dis. 2015 Jan;21(1):142-5.Full text Abstract
55. Skowronski DM, Chambers C, Gustafson R, et al. Avian influenza A(H7N9) virus infection in 2 travelers returning from China to Canada, January 2015. Emerg Infect Dis. 2016 Jan;22(1):71-4.Full text Abstract
56. Xiang N, Li X, Ren R, et al. Assessing change in avian influenza A(H7N9) virus infections during the fourth epidemic - China, September 2015-August 2016. MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1390-4.Full text Abstract
57. Xu L, Bao L, Deng W, et al. Rapid adaptation of avian H7N9 virus in pigs. Virology. 2014 Feb 14;452-453:231-6.Full text Abstract
58. Zhou P, Hong M, Merrill MM, et al. Serological report of influenza A (H7N9) infections among pigs in Southern China. BMC Vet Res. 2014 Sep 2;10:203.Full text Abstract
59. Yum J, Park EH, Ku KB, et al. Low infectivity of a novel avian-origin H7N9 influenza virus in pigs. Arch Virol. 2014 Jun 7;159(10):2745-9. Abstract
60. Wang C, Wang J, Su W, et al. Relationship between domestic and wild birds in live poultry market and a novel human H7N9 virus in China. J Infect Dis. 2014 Jan 1;209(1):34-7.Full text Abstract
61. Jones JC, Sonnberg S, Koçer ZA, et al. Possible role of songbirds and parakeets in transmission of influenza A(H7N9) virus to humans. Emerg Infect Dis. 2014 Mar;20(3):380-5.Full text Abstract
62. Zhao B, Zhang X, Zhu W, et al. Novel avian influenza A(H7N9) virus in tree sparrow, Shanghai, China, 2013. Emerg Infect Dis. 2014 May;20(5):850-3.Full text Abstract
63. Kang M, Lau EHY, Guan W, et al. Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017. Euro Surveill. 2017 Jul 6;22(27):30568.Full text Abstract
64. Lee SS, Wong NS, Leung CC. Exposure to avian influenza H7N9 in farms and wet markets. Lancet. 2013 May 25;381(9880):1815. Abstract
65. Yang S, Chen Y, Cui D, et al. Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study. J Infect Dis. 2014 Jan 15;209(2):265-9.Full text Abstract
66. Quan C, Wang Q, Zhang J, et al. Avian influenza A viruses among occupationally exposed populations, China, 2014-2016. Emerg Infect Dis. 2019 Dec;25(12):2215-25. Abstract
67. Yang P, Ma C, Cui S, et al. Avian influenza A(H7N9) and (H5N1) infections among poultry and swine workers and the general population in Beijing, China, 2013-2015. Sci Rep. 2016 Sep 27;6:33877. Abstract
68. Ma MJ, Zhao T, Chen SH, et al. Avian influenza A virus infection among workers at live poultry markets, China, 2013-2016. Emerg Infect Dis. 2018 Jul;24(7):1246-56. Abstract
69. Bai T, Zhou J, Shu Y. Serologic study for influenza A (H7N9) among high-risk groups in China. N Engl J Med. 2013 Jun 13;368(24):2339-40.Full text Abstract
70. Pan H, Zhang X, Hu J, et al. A case report of avian influenza H7N9 killing a young doctor in Shanghai, China. BMC Infect Dis. 2015 Jun 23;15:237.Full text Abstract
71. Farooqui A, Liu W, Zeng T, et al. Probable hospital cluster of H7N9 influenza infection. N Engl J Med. 2016 Feb 11;374(6):596-8.Full text Abstract
72. Fang CF, Ma MJ, Zhan BD, et al. Nosocomial transmission of avian influenza A (H7N9) virus in China: epidemiological investigation. BMJ. 2015 Nov 19;351:h5765.Full text Abstract
73. Chen H, Liu S, Liu J, et al. Nosocomial co-transmission of avian influenza A(H7N9) and A(H1N1)pdm09 viruses between 2 patients with hematologic disorders. Emerg Infect Dis. 2016 Apr;22(4):598-607.Full text Abstract
74. World Health Organization. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010. Wkly Epidemiol Rec. 2010 Mar 12;85(11):100-7. Abstract
75. Butt KM, Smith GJ, Chen H, et al. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol. 2005 Nov;43(11):5760-7.Full text Abstract
76. Bos ME, Te Beest DE, van Boven M, et al. High probability of avian influenza virus (H7N7) transmission from poultry to humans active in disease control on infected farms. J Infect Dis. 2010 May 1;201(9):1390-6.Full text Abstract
77. Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet. 2004 Feb 21;363(9409):587-93. Abstract
78. Arzey GG, Kirkland PD, Arzey KE, et al. Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia. Emerg Infect Dis. 2012 May;18(5):814-6.Full text Abstract
79. Wei SH, Yang JR, Wu HS, et al. Human infection with avian influenza A H6N1 virus: an epidemiological analysis. Lancet Respir Med. 2013 Dec;1(10):771-8. Abstract
80. Tong S, Zhu X, Li Y, et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013;9(10):e1003657.Full text Abstract
81. Wu Y, Wu Y, Tefsen B, et al. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol. 2014 Apr;22(4):183-91. Abstract
82. Yamada S, Suzuki Y, Suzuki T, et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature. 2006 Nov 16;444(7117):378-82. Abstract
83. Peng J, Yang H, Jiang H, et al. The origin of novel avian influenza A (H7N9) and mutation dynamics for its human-to-human transmissible capacity. PLoS One. 2014 Mar 26;9(3):e93094.Full text Abstract
84. World Health Organization. Human infection with avian influenza A(H7N9) virus - China. Feb 2017 [internet publication].Full text
85. Zhu W, Zhou J, Li Z, et al. Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017. Euro Surveill. 2017 May 11;22(19):30533.Full text Abstract
86. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009 Jun 18;360(25):2605-15.Full text Abstract
87. Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol. 2005 Aug;3(8):591-600. Abstract
88. Virlogeux V, Li M, Tsang TK, et al. Estimating the distribution of the incubation periods of human avian influenza A(H7N9) virus infections. Am J Epidemiol. 2015 Oct 15;182(8):723-9.Full text Abstract
89. Zhou L, Li Q, Uyeki TM. Estimated incubation period and serial interval for human-to-human influenza A(H7N9) virus transmission. Emerg Infect Dis. 2019 Oct 17;25(10):1982-3.Full text Abstract
90. van Riel D, Leijten LM, de Graaf M, et al. Novel avian-origin influenza A (H7N9) virus attaches to epithelium in both upper and lower respiratory tract of humans. Am J Pathol. 2013 Oct;183(4):1137-43.Full text Abstract
91. Chan MC, Chan RW, Chan LL, et al. Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract. Lancet Respir Med. 2013 Sep;1(7):534-42. Abstract
92. Siegers JY, Short KR, Leijten LM, et al. Novel avian-origin influenza A (H7N9) virus attachment to the respiratory tract of five animal models. J Virol. 2014 Apr;88(8):4595-9.Full text Abstract
93. Watanabe T, Kiso M, Fukuyama S, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature. 2013 Sep 26;501(7468):551-5.Full text Abstract
94. Zhu H, Wang D, Kelvin DJ, et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science. 2013 Jul 12;341(6142):183-6. Abstract
95. Mok CK, Lee HH, Chan MC, et al. Pathogenicity of the novel A/H7N9 influenza virus in mice. MBio. 2013 Jul 2;4(4):e00362-13.Full text Abstract
96. Chi Y, Zhu Y, Wen T, et al. Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. J Infect Dis. 2013 Dec 15;208(12):1962-7.Full text Abstract
97. Wang Z, Zhang A, Wan Y, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):769-74.Full text Abstract
98. Everitt AR, Clare S, Pertel T, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature. 2012 Mar 25;484(7395):519-23.Full text Abstract
99. Zhang YH, Zhao Y, Li N, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun. 2013;4:1418.Full text Abstract
100. Lee N, Cao B, Ke C, et al. IFITM3, TLR3, and CD55 genes SNPs and cumulative genetic risks for severe outcomes in Chinese patients with H7N9 / H1N1pdm09 influenza. J Infect Dis. 2017 Jul 1;216(1):97-104. Abstract
101. Yu L, Wang Z, Chen Y, et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis. 2013 Nov;57(10):1449-57.Full text Abstract
102. Lu S, Li T, Xi X, et al. Prognosis of 18 H7N9 avian influenza patients in Shanghai. PLoS One. 2014 Apr 2;9(4):e88728.Full text Abstract
103. Ai J, Huang Y, Xu K, et al. Case-control study of risk factors for human infection with influenza A(H7N9) virus in Jiangsu Province, China, 2013. Euro Surveill. 2013 Jun 27;18(26):20510. Abstract
104. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005 Sep 29;353(13):1374-85.Full text Abstract
105. Ortiz JR, Katz MA, Mahmoud MN, et al. Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. J Infect Dis. 2007 Dec 1;196(11):1685-91.Full text Abstract
106. Ma MJ, Ma GY, Yang XX, et al. Avian Influenza A(H7N9) virus antibodies in close contacts of infected persons, China, 2013-2014. Emerg Infect Dis. 2015 Apr;21(4):709-11.Full text Abstract
107. Lv H, Han J, Zhang P, et al. Mild illness in avian influenza A(H7N9) virus-infected poultry worker, Huzhou, China, April 2013. Emerg Infect Dis. 2013 Nov;19(11):1885-8.Full text Abstract
108. Chen Z, Liu H, Lu J, et al. Asymptomatic, mild, and severe influenza A(H7N9) virus infection in humans, Guangzhou, China. Emerg Infect Dis. 2014 Sep;20(9):1535-40.Full text Abstract
109. Gao HN, Lu HZ, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013 Jun 13;368(24):2277-85.Full text Abstract
110. Ke C, Mok CKP, Zhu W, et al. Human infection with highly pathogenic avian influenza A(H7N9) virus, China. Emerg Infect Dis. 2017 Jul;23(8):1332-40.Full text Abstract
111. Yang Y, Wong G, Yang L, et al. Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: clinical and virological findings. J Infect. 2019 Jan 18;78(3):241-8. Abstract
112. Centers for Disease Control and Prevention. Interim guidance on testing and specimen collection for patients with suspected infection with novel influenza A viruses with the potential to cause severe disease in humans. Mar 2022 [internet publication].Full text
113. World Health Organization. Real-time RT-PCR protocol for the detection of avian influenza A(H7N9) virus. Apr 2013 [internet publication].Full text
114. Torres A, Lee N, Cilloniz C, et al. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J. 2016 Dec;48(6):1764-78.Full text Abstract
115. World Health Organization. WHO information for the molecular detection of influenza viruses. Feb 2021 [internet publication].Full text
116. Centers for Disease Control and Prevention. Diagnostics for detecting H7N9 using rRT-PCR. May 2022 [internet publication].Full text
117. Centers for Disease Control and Prevention. Interim guidance for infection control within healthcare settings when caring for confirmed cases, probable cases, and cases under investigation for infection with novel influenza A viruses associated with severe disease. Mar 2022 [internet publication].Full text
118. Baas C, Barr IG, Fouchier RA, et al. A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus, 2013. Euro Surveill. 2013 May 23;18(21):20487.Full text Abstract
119. Chan KH, To KK, Chan JF, et al. Analytical sensitivity of seven point-of-care influenza virus detection tests and two molecular tests for detection of avian origin H7N9 and swine origin H3N2 variant influenza A viruses. J Clin Microbiol. 2013 Sep;51(9):3160-1.Full text Abstract
120. Feng F, Jiang Y, Yuan M, et al. Association of radiologic findings with mortality in patients with avian influenza H7N9 pneumonia. PLoS One. 2014 Apr 4;9(4):e93885.Full text Abstract
121. Zhu Y, Qi X, Cui L, et al. Human co-infection with novel avian influenza A H7N9 and influenza A H3N2 viruses in Jiangsu province, China. Lancet. 2013 Jun 15;381(9883):2134. Abstract
122. Zhang W, Zhu D, Tian D, et al. Co-infection with avian (H7N9) and pandemic (H1N1) 2009 influenza viruses, China. Emerg Infect Dis. 2015 Apr;21(4):715-8.Full text Abstract
123. Centers for Disease Control and Prevention. Case definitions for investigations of human infection with avian influenza A viruses in the United States. Mar 2022 [internet publication].Full text
124. UK Health Security Agency. Investigation and initial clinical management of possible human cases of avian influenza with potential to cause severe human disease. Nov 2021 [internet publication].Full text
125. Centers for Disease Control and Prevention. Interim guidance on follow-up of close contacts of persons infected with novel influenza A viruses and use of antiviral medications for chemoprophylaxis. Mar 2022 [internet publication].Full text
126. Centers for Disease Control and Prevention. Interim guidance on influenza antiviral chemoprophylaxis of persons exposed to birds with avian influenza A viruses associated with severe human disease or with the potential to cause severe human disease. Mar 2022 [internet publication].Full text
127. World Health Organization. Guidelines for the clinical management of severe illness from influenza virus infections. 2022 [internet publication].Full text
128. Centers for Disease Control and Prevention. Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. Mar 2022 [internet publication].Full text
129. Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Sep 2022 [internet publication].Full text
130. Ikematsu H, Kawai N. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza. Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. Abstract
131. Duval X, van der Werf S, Blanchon T, et al; Bivir Study Group. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med. 2010 Nov 2;7(11):e1000362.Full text Abstract
132. Zheng S, Tang L, Gao H, et al. Benefit of early initiation of neuraminidase inhibitor treatment to hospitalized patients with avian influenza A(H7N9) virus. Clin Infect Dis. 2018 Mar 19;66(7):1054-60.Full text Abstract
133. Wang Y, Guo Q, Yan Z, et al; CAP-China Network. Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection. J Infect Dis. 2018 May 5;217(11):1708-17.Full text Abstract
134. Zheng S, Zou Q, Wang X, et al. Factors associated with fatality due to avian influenza A(H7N9) infection in China. Clin Infect Dis. 2020 Jun 24;71(1):128-32. Abstract
135. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006 Oct;12(10):1203-7.Full text Abstract
136. Kandeel A, Manoncourt S, Abd el Kareem E, et al. Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006-2009. Emerg Infect Dis. 2010 Jul;16(7):1101-7.Full text Abstract
137. Kandun IN, Tresnaningsih E, Purba WH, et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet. 2008 Aug 30;372(9640):744-9. Abstract
138. Adisasmito W, Chan PK, Lee N, et al. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. J Infect Dis. 2010 Oct 15;202(8):1154-60.Full text Abstract
139. Chan PK, Lee N, Zaman M, et al. Determinants of antiviral effectiveness in influenza virus A subtype H5N1. J Infect Dis. 2012 Nov;206(9):1359-66.Full text Abstract
140. Oner AF, Dogan N, Gasimov V, et al. H5N1 avian influenza in children. Clin Infect Dis. 2012 Jul;55(1):26-32.Full text Abstract
141. Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014 May;2(5):395-404. Abstract
142. Lee N, Leo YS, Cao B, et al. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. Eur Respir J. 2015 Jun;45(6):1642-52.Full text Abstract
143. Taniguchi K, Ando Y, Nobori H, et al. Inhibition of avian-origin influenza A(H7N9) virus by the novel cap-dependent endonuclease inhibitor baloxavir marboxil. Sci Rep. 2019 Mar 5;9(1):3466.Full text Abstract
144. Arabi Y, Gomersall CD, Ahmed QA, et al. The critically ill avian influenza A (H5N1) patient. Crit Care Med. 2007 May;35(5):1397-403. Abstract
145. Cao B, Gao H, Zhou B, et al. Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia. Crit Care Med. 2016 Jun;44(6):e318-28. Abstract
146. Li TC, Chan MC, Lee N. Clinical implications of antiviral resistance in influenza. Viruses. 2015 Sep 14;7(9):4929-44.Full text Abstract
147. Ariano RE, Sitar DS, Zelenitsky SA, et al. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ. 2010 Mar 9;182(4):357-63.Full text Abstract
148. Taylor WR, Thinh BN, Anh GT, et al. Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza. PLoS One. 2008;3(10):e3410.Full text Abstract
149. Wu XX, Gao HN, Wu HB, et al. Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma. Int J Infect Dis. 2015 Dec;41:3-5.Full text Abstract
150. Furuta Y, Gowen BB, Takahashi K, et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res. 2013 Nov;100(2):446-54.Full text Abstract
151. European Centre for Disease Prevention and Control. Rapid risk assessment: human infection with avian influenza A viruses, China. Feb 2014 [internet publication].Full text
152. Wang C, Yu H, Horby PW, et al. Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis. 2014 Apr;58(8):1095-103.Full text Abstract
153. Lee CM, Hudson LD. Long-term outcomes after ARDS. Semin Respir Crit Care Med. 2001 Jun;22(3):327-36. Abstract
Use of this content is subject to our disclaimer